Skip to main content
OpenTrials
Completed

NCT Number: NCT03928951

General Practitioner Reassessment of Urinary Infection Antibiotherapy Prescribed by Emergency Departments

Urinary infections are at the origin of many emergency department consultations and antibiotic prescriptions. Increase of bacteria resistance to antibiotics is promoted by an inappropriate use of those antibiotics but initial prescription in emergency departments is complicated by brief clinical examinations, unavailable sampling results and risks of multi-resistant bacteria. Large diffusion of new recommendations for urinary infection management should improve the quality of initial antibiotic prescription. However emergency physicians have no knowledge of the reassessment of antibiotherapy 48 to 72 hours after initial prescription by general practitioners which is a quality criterion of good antibiotic use. The main purpose of this study is to estimate the reassessment rate by general practitioners of the urinary infection antibiotherapies prescribed in emergency departments. This will allow assessing the quality of initial antibiotic prescription and help to improve practices.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer

Toulon, Var, 83056, France

About this study

Urinary infections are at the origin of many emergency department consultations and antibiotic prescriptions. Increase of bacteria resistance to antibiotics is promoted by an inappropriate use of those antibiotics but initial prescription in emergency departments is complicated by brief clinical examinations, unavailable sampling results and risks of multi-resistant bacteria. Large diffusion of new recommendations for urinary infection management should improve the quality of initial antibiotic prescription. However emergency physicians have no knowledge of the reassessment of antibiotherapy 48 to 72 hours after initial prescription by general practitioners which is a quality criterion of good antibiotic use. The main purpose of this study is to estimate the reassessment rate by general practitioners of the urinary infection antibiotherapies prescribed in emergency departments.

Patients will be informed during their consultation in one of Toulon - La Seyne sur Mer hospital emergency departments. If they don't express opposition to their data collection, they will be included. A form will then be completed by emergency physicians with initial prescribed antibiotherapy, patients' general practitioners contact information and if patients have a shared medical file or not. 4 to 5 days later, patients' general practitioners will be contacted to know if urinary analysis results were transferred from emergency department to practitioners, if antibiotherapy was modified and if patients' shared medical file was consulted.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Every patient more than 18 years who was administered antibiotherapy for urinary infection in emergency department or for whom urinary infection was diagnosed in emergency department (cystitis, acute pyelonephritis, prostatitis)

Exclusion criteria

  • Patients less than 18 years old
  • Patients opposed to their data use
  • Patients hospitalized more than 24 hours
  • Patients taking antibiotherapy already before their arrival in emergency department
  • Patients without sufficient reading capacities or understanding of french language to express opposition to their research participation
  • Any other reason which, according to investigator, might interfere with research objective evaluation

Treatment and study plan

General practitioner reassessment of urinary infection antibiotherapy prescribed by emergency departments

Other

Antibiotherapy will be prescribed by emergency physicians and general practitioners will be contacted 4 to 5 days later to know if antibiotherapy was modified

Primary outcomes

  1. Rate of antibiotherapies modified by general practitioners

    Time frame: 6 months

    Number of antibiotic prescriptions modified by general practitioners divided by the total number of initial antibiotic prescriptions

Secondary outcomes

  1. Rate of initial antibiotherapies not relevant to recommendations

    Time frame: 6 months

    Number of initial antibiotic prescriptions not relevant to recommendations divided by the total number of initial antibiotic prescriptions

  2. Rate of initial antibiotherapies not consistent with recommendations

    Time frame: 6 months

    Number of initial antibiotic prescriptions not consistent (molecule, dose, period of time) with recommendations divided by the total number of initial antibiotic prescriptions

  3. Rate of reassessments not relevant to recommendations

    Time frame: 6 months

    Number of antibiotic prescription modifications not relevant to recommendations divided by the total number of antibiotic prescription modifications

  4. Rate of reassessments not consistent with recommendations

    Time frame: 6 months

    Number of antibiotic prescription modifications not consistent (molecule, dose, period of time) with recommendations divided by the total number of antibiotic prescription modifications

  5. Frequence of use of shared medical file

    Time frame: 6 months

    Number of patients for which the shared medical file is used divided by the total number of patients enrolled

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Other

Registry information

Official study title

General Practitioner Reassessment of the Antibiotherapy of Urinary Infections Initially Treated in Emergency Departments

Acronym: ATB-IU

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 26, 2019
Registry last updated
Nov 29, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.